Back
Fate Therapeutics Stock Predictions
Sponsored
FATE
Sponsored
NEW: AI Breakthrough to Send Economy Skyrocketing by $200 Trillion?
And with the one move I detail here, you can secure a share of this 10,000% boom.
Sell
43
FATE
Fate Therapeutics
Last Price:
7.34
Seasonality Move:
-7.49%
7 Day Trial
ALL ACCESS PASS
$
7
$200 Trillion "AI Phase 2" Moments Away?
And if you click here now, you'll see how YOU could get a piece of the action...Fate Therapeutics Stock Forecast
- Over the next 52 weeks, Fate Therapeutics has on average historically risen by 44.7% based on the past 10 years of stock performance.
- Fate Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Fate Therapeutics Stock Undervalued?
The current Fate Therapeutics [FATE] share price is $7.34. The Score for FATE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal. - FATE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Fate Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Fate Therapeutics has on average historically risen by 44.7% based on the past 10 years of stock performance.
Fate Therapeutics Stock Rating
Sell
43
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics overpriced?
- Fate Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Fate Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
fatetherapeutics.com
52-Week Data
52-Week High:
8.83
52-Week Low:
1.63
Prediction Charts
Market Cap:
728.4M
Price in USD:
7.34
Volume:
2.71M
Beta:
1.75
Technical Analysis
SMA50:
6.63
SMA100:
4.82
SMA200:
4.02
52-Wk Change:
39.28%
Stock Predictions
-
Is Fate Therapeutics stock public?
Yes, Fate Therapeutics is a publicly traded company. -
What is the Fate Therapeutics stock quote today?
The Fate Therapeutics stock price is 7.34 USD today. -
How to buy Fate Therapeutics stock online?
You can buy Fate Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-11 | 8.15 | 7.89 | 8.44 | 7.86 |
Mar-12 | 7.83 | 7.66 | 8.27 | 7.65 |
Mar-13 | 7.60 | 7.63 | 7.98 | 7.40 |
Mar-14 | 7.62 | 7.23 | 7.67 | 6.91 |
Mar-15 | 7.24 | 7.49 | 7.70 | 7.21 |
Mar-18 | 7.49 | 7.03 | 7.50 | 6.95 |
Mar-19 | 6.83 | 7.00 | 7.28 | 6.80 |
Mar-20 | 6.95 | 7.44 | 7.66 | 6.78 |
Mar-21 | 7.51 | 7.43 | 7.70 | 7.19 |
Mar-22 | 7.47 | 6.61 | 7.59 | 6.61 |
Mar-25 | 6.58 | 6.87 | 7.01 | 6.54 |
Mar-26 | 7.03 | 6.86 | 7.13 | 6.68 |
Mar-27 | 6.97 | 7.34 | 7.37 | 6.77 |
Mar-28 | 7.27 | 7.34 | 7.65 | 7.23 |
Fate Therapeutics Earnings
Fate Therapeutics Earnings Report: Per Share Fate Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Fate Therapeutics Forecast Revenue Growth
Fate Therapeutics Stock Analysis: Historical quarterly revenues per share for Fate Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.
* Fate Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.